AUO Corporation ("AUO")(TSE: 2409)  today announced that as part of its biaxial transformation strategy, AUO's Board of Directors resolved to acquire 5.0% to 30.0% shares of Crystalvue Medical Corporation ("Crystalvue") (TSE: 6527) through AUO's subsidiary AUO Display Plus Corporation ("AUO Display Plus") via tender offer. Through this tender offer, both Crystalvue and AUO Display Plus look forward to jointly combining their strengths in optics and display technologies to vertically develop the smart healthcare market.

AUO is proactively advancing its biaxial transformation strategy, developing its high-value-added display technology, Go Premium, while extending the vertical market applications of its display technology, Go Vertical. AUO's subsidiary, AUO Display Plus, focuses on specific segments of the vertical market, such as smart education and enterprise, smart retail, smart healthcare, and smart mobility, and is working with ecosystem partners to jointly develop value-added display applications and provide hardware and software integration solutions. Amid the trend of digital transformation in technologies, such as precision medicine, telemedicine, personalized prevention, and other areas, AUO Display Plus leverages its cutting-edge medical image display capabilities and focuses on fields such as smart operating rooms, examination and diagnosis, and integrated medical information and management, and continues to collaborate with partners in the healthcare ecosystem to provide comprehensive smart healthcare solutions.

Crystalvue is a leading manufacturer of high-end ophthalmic medical equipment in Taiwan. Crystalvue has the ability to integrate optical, mechanical, electronic, and software technologies and has accumulated considerable experience in related quality certifications. In recent years, Crystalvue has developed its own branded products, such as the Automatic Non-Mydriatic Retinal Camera, distributed in over 80 countries.